 |
Depósito mínimo $50 Promoção exclusiva |
Nossa pontuação |
0% comissão |
Are you looking to buy Intercept Pharmaceuticals stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:ICPT! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Intercept Pharmaceuticals stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Its lead products candidate is the Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid in adults. The company is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis (NASH); and several other product candidates in various stages of clinical and preclinical development. It has a license agreement with Sumitomo Dainippon Pharma Co. Ltd. for the research, development, and commercialization of OCA as a therapeutic for the treatment of PBC and NASH in Japan and China; and Aralez Pharmaceuticals Canada Inc to develop and commercialize bezafibrate in the United States. The company markets its products through an internal commercial organization, a contract sales organization, and third-party distributors. Intercept Pharmaceuticals, Inc. was founded in 2002 and is headquartered in New York, New York.
Volume médio
1,20 milhões de shms
MERCADO CAP
$1,18 bilhões
Bolsa de Valores
NASDAQ
Comprem essas ações!
|
NOME
|
TICKER
|
INDÚSTRIA
|
SECTOR
|
VOLUME
|
COMPRAR AGORA ESSAS AÇÕES
|
|---|---|---|---|---|---|
|
NASDAQ:ICPT
|
Preparações farmacêuticas
|
Médico
|
11,332 shs
|
Below is a quick guide on how to buy NASDAQ:ICPT stocks safe, fast and around the world in less than five minutes.
Passo 1: Abrir uma conta no eToro – eToro is the best broker to buy Intercept Pharmaceuticals shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: Carregue sua identificação - Conforme os regulamentos da KYC, eToro lhe pedirá que carregue uma cópia de seu passaporte ou de sua carteira de motorista.
Etapa 3: Fundos de depósito - Deposite algum dinheiro em sua recém-criada conta eToro. O senhor pode escolher entre transferência bancária, carteira eletrônica, cartão de débito/crédito ou Paypal.
Passo 4: Buy Intercept Pharmaceuticals – Search for “”NASDAQ:ICPT”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Intercept Pharmaceuticals stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
24 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Intercept Pharmaceuticals in the last year. There are currently 1 sell rating, 15 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “hold” Intercept Pharmaceuticals stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ICPT, but not buy additional shares or sell existing shares.
Wall Street analysts have given Intercept Pharmaceuticals a “Hold” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Intercept Pharmaceuticals wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
2 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
3 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:ICPT stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Intercept Pharmaceuticals stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Intercept Pharmaceuticals stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Como o eToro é uma plataforma regulamentada, o senhor precisará completar o processo KYC, isso é uma prática padrão e leva apenas alguns minutos. O senhor precisará fornecer um documento de identificação com foto (passaporte, carteira de motorista) e comprovante de endereço (conta de serviços públicos, extrato bancário).
Uma vez que o senhor tenha se inscrito e verificado sua conta, precisará depositar fundos. eToro aceita cartões de crédito/débito, transferências bancárias, e também carteiras eletrônicas. Portanto, qualquer que seja sua preferência, haverá algo para o senhor.
Now that you’ve funded your eToro account, just type “NASDAQ:ICPT stocks” na barra de busca na parte superior da tela e pressione "trade".
All that’s left is to buy some NASDAQ:ICPT stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:ICPT is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Intercept Pharmaceuticals stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Intercept Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, February 23rd 2021.
View our earnings forecast for Intercept Pharmaceuticals.
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) issued its quarterly earnings results on Monday, November, 9th. The biopharmaceutical company reported ($2.01) earnings per share for the quarter, missing the consensus estimate of ($1.96) by $0.05. The biopharmaceutical company earned $79.50 million during the quarter, compared to analysts’ expectations of $78.60 million. Intercept Pharmaceuticals had a negative trailing twelve-month return on equity of 1,973.10% and a negative net margin of 106.64%. The business’s revenue for the quarter was up 28.2% compared to the same quarter last year. During the same period in the previous year, the company posted ($2.59) earnings per share.
View Intercept Pharmaceuticals’ earnings history.
Intercept Pharmaceuticals’ stock was trading at $77.60 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ICPT stock has decreased by 54.6% and is now trading at $35.20.
24 brokerages have issued 12-month target prices for Intercept Pharmaceuticals’ shares. Their forecasts range from $27.00 to $106.00. On average, they anticipate Intercept Pharmaceuticals’ stock price to reach $58.74 in the next twelve months. This suggests a possible upside of 66.9% from the stock’s current price.
View analysts’ price targets for Intercept Pharmaceuticals or view top-rated stocks among Wall Street analysts.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:ICPT stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mais de 95% de fundos de clientes são mantidos offline, em câmara fria, o que é crucial para qualquer corretor que administre seus ativos. Independentemente de quão segura deve ser uma plataforma, recomendamos o uso do 2FA para acrescentar uma camada adicional de segurança à sua conta.
eToro oferece aos usuários uma gama de recursos para começar a investir o mais rapidamente possível. Eles têm uma característica relativamente única chamada negociação de cópias, que lhe permite ganhar uma renda passiva ao espelhar comerciantes experientes, o que lhe permite começar a ter lucro rapidamente, e lhe dá uma melhor compreensão das estratégias usadas pelos profissionais. Além disso, o eToro permite aos usuários investir em carteiras administradas, sendo uma carteira administrada uma variedade de ativos semelhantes agrupados, permitindo ao senhor diversificar sua conta, reduzindo qualquer risco potencial. Para aqueles com experiência anterior em negociação, o senhor pode investir em mercados fora das ações, já que eToro permite aos usuários negociar ETFs, commodities, criptografia e índices. Se o senhor já investir fora do espaço da bolsa de valores, isso pode ser muito útil, pois permite ao senhor administrar todos os seus investimentos em um só lugar.
Intercept Pharmaceuticals’ management team includes the following people:
Mr. Jerome B. Durso, Pres & CEO (Age 53, Pay $953.9k)
Mr. Sandip S. Kapadia CPA, M.B.A., CFO, Treasurer & Principal Accounting Officer (Age 51, Pay $738.4k)
Dr. Mark Pruzanski, Founder, Advisor & Director (Age 53, Pay $1.3M)
Mr. Richard Kim, Pres of U.S. Commercial & Strategic Marketing (Age 52, Pay $987.56k)
Ms. Lisa M. DeFrancesco, VP of Investor Relations
Mr. David Ford, Chief HR Officer (Age 52)
Ms. Lisa Bright Morrison, Pres of International (Age 53)
Dr. Christian Weyer, Exec. VP of R&D (Age 51)
Dr. Gail Cawkwell, Sr. VP of Medical Affairs, Safety & Pharmacovigilance (Age 59)
Dr. Jason A. Campagna, Chief Medical Officer (Age 51)
32 employees have rated Intercept Pharmaceuticals CEO Mark Pruzanski on Glassdoor.com. Mark Pruzanski has an approval rating of 80% among Intercept Pharmaceuticals’ employees.
Os CFDs são instrumentos complexos e vêm com um alto risco de perder dinheiro rapidamente devido à alavancagem. 68% de contas de investidores de varejo perdem dinheiro ao negociar CFDs com esse provedor. O senhor deve considerar se compreende como os CFDs funcionam, e se pode arcar com o alto risco de perder seu dinheiro.
Some companies that are related to Intercept Pharmaceuticals include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Seagen (SGEN), Alexion Pharmaceuticals (ALXN), Exact Sciences (EXAS), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), Novavax (NVAX), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX) and Ionis Pharmaceuticals (IONS).
View all of ICPT’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Intercept Pharmaceuticals investors own include Sarepta Therapeutics (SRPT), Gilead Sciences (GILD), Tesla (TSLA), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Micron Technology (MU), Ionis Pharmaceuticals (IONS), Regeneron Pharmaceuticals (REGN) and Biogen (biib).
Intercept Pharmaceuticals trades on the NASDAQ under the ticker symbol “ICPT.”
Intercept Pharmaceuticals’ stock is owned by a number of institutional and retail investors. Top institutional shareholders include First Trust Advisors LP (5.93%), Assenagon Asset Management S.A. (0.54%), Pinnacle Associates Ltd. (0.41%), Russell Investments Group Ltd. (0.37%), Fisher Asset Management LLC (0.18%) and Los Angeles Capital Management LLC (0.12%). Company insiders that own Intercept Pharmaceuticals stock include Christian Weyer, David A Ford, David Shapiro, Gail Cawkwell, Jason Campagna, Lisa Bright, Luca Benatti, Mark Pruzanski, Paolo Fundaro, Ryan T Sullivan, Sandip Kapadia, SPA Genextra and Srinivas Akkaraju.
View institutional ownership trends for Intercept Pharmaceuticals.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
ICPT stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Assenagon Asset Management S.A., Pinnacle Associates Ltd., State of Wisconsin Investment Board, Fisher Asset Management LLC, and Dupont Capital Management Corp. Company insiders that have sold Intercept Pharmaceuticals company stock in the last year include Christian Weyer, David A Ford, Jason Campagna, Paolo Fundaro, Sandip Kapadia, and SPA Genextra.
View insider buying and selling activity for Intercept Pharmaceuticals or view top insider-selling stocks.
ICPT stock was purchased by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Los Angeles Capital Management LLC, Formidable Asset Management LLC, SG Americas Securities LLC, AE Wealth Management LLC, Pacer Advisors Inc., and Aperio Group LLC. Company insiders that have bought Intercept Pharmaceuticals stock in the last two years include Luca Benatti, and Srinivas Akkaraju.
View insider buying and selling activity for Intercept Pharmaceuticals or or view top insider-buying stocks.
Shares of ICPT can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revisão dos Corretores Interativos, Revisão eToro, Revisão DEGiro, Revisão da AvaTrade, IG Markets Review, Revisão dos Mercados de IC, CMC Markets Review, Admiral Markets Review e muitos mais. Leia uma das revisões para saber tudo sobre o corretor e comece agora a comprar ações.
One share of ICPT stock can currently be purchased for approximately $35.20.
Intercept Pharmaceuticals has a market capitalization of $1.16 billion and generates $252 million in revenue each year. The biopharmaceutical company earns $-344,680,000.00 in net income (profit) each year or ($10.89) on an earnings per share basis.
Intercept Pharmaceuticals employs 583 workers across the globe.
No Reportlab.org queremos garantir que o senhor tenha todas as informações mais relevantes sobre compra de ações. Trazemos-lhe os melhores guias sobre o mercado de ações, com revisões pessoais, informações de base, revisões de plataforma, como fazer e muito mais. Deseja obter outras informações? Então confira os Ações OTC, Ações da NASDAQ, Ações da NYSE, Ações LONES, Ações de FRA, Ações ETR, Ações da APE, Ações TSX ou Ações Amex. Procurando informações mais detalhadas como Ações de 5g, ações biotecnológicas, estoques de ouro e outras informações de nosso reportlab.
How can you buy Intercept Pharmaceuticals stock on the internet?
You can easily buy Intercept Pharmaceuticals stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Outra opção é usar um corretor regulamentado como Mercados de IC ou Corretores Interativos. You can an account with these brokers and start buying or trading NASDAQ:ICPT stocks in a safe and complete environment to trade in.
Where to buy Intercept Pharmaceuticals stock?
You will first want to find a licensed broker that supports NASDAQ:ICPT stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:ICPT stocks in a safe and complete environment.
Is NASDAQ:ICPT stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:ICPT stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Intercept Pharmaceuticals stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:ICPT is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Intercept Pharmaceuticals stock.
How do you trade Intercept Pharmaceuticals stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Intercept Pharmaceuticals stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:ICPT stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Intercept Pharmaceuticals stock?
To sell your NASDAQ:ICPT stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Intercept Pharmaceuticals stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:ICPT stock.
Stephen sabe muito sobre produtos financeiros e, em particular, tem uma grande paixão pelas bolsas de valores e por seus participantes. Esperamos que a informação fornecida ajude o senhor. Algo não está muito claro? Queira deixar suas perguntas ou comentários no final da página.
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ |
Boletim informativo
Notícias recentes
| |
Nossa pontuação |
0% comissão |
Ações em tempo real e dados criptográficos
Notificações, Dicas e Notícias
Melhores Ações e Guias Criptográficos
Corretor Online & Câmbio de Revisões
Reportlab Finanças é puramente um website informativo e em nenhum caso implica aconselhamento sobre investimentos. Todos os investimentos comportam riscos e o senhor pode perder todos os seus investimentos. Não invista dinheiro que o senhor não pode perder.
Reportlab Finanças
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos os direitos reservados.
